PMC:7600245 / 75527-75950
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T324 | 370-375 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T363 | 109-117 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T774 | 333-336 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T775 | 370-375 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T776 | 418-421 | http://purl.obolibrary.org/obo/CLO_0001196 | denotes | 225 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T59923 | 93-105 | Chemical | denotes | nitric oxide | http://purl.obolibrary.org/obo/CHEBI_16480 |
| T366 | 100-105 | Chemical | denotes | oxide | http://purl.obolibrary.org/obo/CHEBI_25741|http://purl.obolibrary.org/obo/CHEBI_29356 |
| T4439 | 162-174 | Chemical | denotes | nitric oxide | http://purl.obolibrary.org/obo/CHEBI_16480 |
| T98960 | 169-174 | Chemical | denotes | oxide | http://purl.obolibrary.org/obo/CHEBI_25741|http://purl.obolibrary.org/obo/CHEBI_29356 |
| T89350 | 217-224 | Chemical | denotes | nitrite | http://purl.obolibrary.org/obo/CHEBI_16301 |
| T60594 | 225-230 | Chemical | denotes | oxide | http://purl.obolibrary.org/obo/CHEBI_25741|http://purl.obolibrary.org/obo/CHEBI_29356 |
| T21822 | 303-310 | Chemical | denotes | quinine | http://purl.obolibrary.org/obo/CHEBI_137041|http://purl.obolibrary.org/obo/CHEBI_15854 |
| T95647 | 387-399 | Chemical | denotes | nitric oxide | http://purl.obolibrary.org/obo/CHEBI_16480 |
| T2548 | 394-399 | Chemical | denotes | oxide | http://purl.obolibrary.org/obo/CHEBI_25741|http://purl.obolibrary.org/obo/CHEBI_29356 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T591 | 0-127 | Sentence | denotes | Currently, there are about 17 clinical trials being performed to evaluate the use of inhaled nitric oxide in COVID-19 patients. |
| T592 | 128-423 | Sentence | denotes | Other forms to indirectly deliver nitric oxide include the intravenous administration of nitrite oxide (NCT04401527; n = 200) or the nasal delivery of GLS-1200 which contains quinine diluted in saline and has been reported to stimulate nasal cells to produce nitric oxide (NCT04408183; n = 225). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2359 | 118-126 | Species | denotes | patients | Tax:9606 |
| 2360 | 93-105 | Chemical | denotes | nitric oxide | MESH:D009569 |
| 2361 | 162-174 | Chemical | denotes | nitric oxide | MESH:D009569 |
| 2362 | 217-230 | Chemical | denotes | nitrite oxide | |
| 2363 | 279-287 | Chemical | denotes | GLS-1200 | |
| 2364 | 303-310 | Chemical | denotes | quinine | MESH:D011803 |
| 2365 | 322-328 | Chemical | denotes | saline | MESH:D012965 |
| 2366 | 387-399 | Chemical | denotes | nitric oxide | MESH:D009569 |
| 2367 | 109-117 | Disease | denotes | COVID-19 | MESH:C000657245 |